Measles and Rubella Combined Vaccine (subcutaneous, live), Beijing Tiantan Biological Products

麻疹风疹联合减毒活疫苗（北京天坛生物制品）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeasles and Rubella Combined Vaccine (subcutaneous, live), Beijing Tiantan Biological Products

Drug Alias NameN/A

ClassificationVaccines > Vaccine type > Combination vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Development/production technology > Live attenuated vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsRubulavirus InfectionsMeasles

Global Approved IndicationsRubulavirus InfectionsMeasles

Approved Indications in ChinaRubulavirus InfectionsMeasles

Original Approved Country/TerritoryMainland China

Original Approved Date2002/08/29

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesBeijing Tiantan Biological Products Corporation Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsRubulavirus InfectionsMeasles

Inactive IndicationsN/A

Other Information

ATC CodeJ07BD53